Shireen Fatemi is an Endocrinology/Metabolic physician affiliated with Kaiser Permanente. OpenAlex indexes 20 publications with 2,094 citations (h-index 14).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
13652 Cantara St
Panorama City, CA 914025423
Telephone
818-375-2000Registry record last updated 1 Dec 2021.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Tandem Diabetes Care, Inc.Program year20231 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
43.4%Insulins and analogues for injection, intermediate-acting11.5%Humulin N52%Humulin N Kwikpen48%Part D≥53 patientsInsulin Analog10.3%Humalog Kwikpen U-10041%Insulin Glargine-Yfgn37%Humalog22%Part D≥39 patients+ 6 more classes in this area
Hormonal (systemic)
30.8%l-Thyroxine19.9%Levothyroxine Sodium100%Part D≥138 patientsThyroid Hormone Synthesis Inhibitor5.6%Methimazole100%Part D≥45 patients+ 4 more classes in this area
Cardiovascular
14.7%Statin5.6%Atorvastatin Calcium58%Simvastatin26%Rosuvastatin Calcium16%Part D<11 patientsBeta blocker2.4%Atenolol62%Metoprolol Tartrate38%Part D<11 patients+ 6 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Improved prediction of hip fracture using multi-faceted biomechanical computed tomography
Journal of Bone and Mineral Research
2025 - Osteoporosis treatment prevents hip fracture similarly in both sexes: the FOCUS observational study
Journal of Bone and Mineral Research
2024 - Influence of Thyroglobulin Autoantibodies on Thyroglobulin Levels Measured by Different Methodologies: IMA, LC-MS/MS, and RIA
The Journal of Clinical Endocrinology & Metabolism
2024 - Osteoporosis and Hip Fracture Risk From Routine Computed Tomography Scans: The Fracture, Osteoporosis, and CT Utilization Study (FOCUS)
Journal of Bone and Mineral Research
2018 - Thyroglobulin2018
Similar KOLs
Other experts from the same institution or the same specialty.
Joseph Presti, MD
Kaiser Permanente
Walter Kinney, MD
Kaiser Permanente
Alexander Flint, MD, PhD
Kaiser Permanente
Jonathan Zaroff, MD
Kaiser Permanente
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”